Trial Profile
Clinical efficacy of Eribulin new for metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2018
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 01 Apr 2018 Status changed from active, no longer recruiting to completed.
- 09 Jul 2014 New trial record